GABA modulation of cocaine self-administration

Annals of the New York Academy of Sciences

Volumn 909, Issue , 2000, Pages 145-158

  Roberts, David C S ^a   Brebner, Karen ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; COCAINE DEPENDENCE; CONFERENCE PAPER; MODULATION; NONHUMAN; REINFORCEMENT;

ANIMALIA;

EID: 0033928661     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06680.x     Document Type: Conference Paper

References (72)

1. 1. BARDO, M.T. 1998. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol. 12: 37-67.
2. 2. KALIVAS, P.W., P. DUFFY & H. EBERHARDT. 1990. Modulation of A10 dopamine neurons by γ-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253: 858-866.
3. 3. KOOB, G.F. & F.E. BLOOM. 1988. Cellular and molecular mechanisms of drug dependence. Science 242: 715-723.
4. 4. BALON, R. 1994. Fluoxetine for cocaine dependence in methadone maintenance. J. Clin. Psychopharm. 14: 360.
5. 5. BERGER, P., F.H. GAWIN & T.R. KOSTEN. 1989. Treatment of cocaine abuse with mazindol. Lancet 333: 283.
6. 6. EILER, K., M.R. SCHAEFER, D. SALSTROM & R. LOWERY. 1995. Double-blind comparison of bromocriptine and placebo in cocaine withdrawal. Am. J. Drug Alcohol Abuse 21: 65-69.
7. 7. GIANNINI, A.J., D.J. FOLTS, J.N. FEATHER & B.S. SULLIVAN. 1989. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res. 29: 11-16.
8. 8. HANDELSMAN, P.L., I.M. ESCOVAR, I.J. MARION & J.H. LOWINSON. 1988. Amantadine for treatment of cocaine dependence in methadone-maintained patients. Am. J. Psychiatry 145: 533.
9. 9. KOSTEN, T.R., B. SCHUMANN, D. WRIGHT, M.K. CARNEY & F.H. GAWIN. 1987. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J. Clin. Psychiatry 48: 442-444.
10. 10. MARGOLIN, A., S.K. AVANTS & T.R. KOSTEN. 1995. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. Am. J. Drug Alcohol Abuse 21: 469-481.
11. 11. CORNISH, J.W., I. MAANY, P.J. FUDALA, S. NEAL, S.A. POOLE, P. VOLPICELLI & C.P. O'BRIEN. 1995. Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend. 38: 221-227.
12. 12. KOSTEN, T.R., H.D. KLEBER & C. MORGAN. 1989. Treatment of cocaine abuse with bupenorphine. Biol. Psychiatry 26: 637-640.
13. 13. KRANZLER, H.R., L.O. BAUER, D. HERSH & V. KLINGHOFFER. 1995. Carbamazepine treatment of cocaine dependence: A placebo-controlled trial. Drug Alcohol Depend. 38: 203-211.
14. 14. LEMERE, F. 1991. Lithium treatment of cocaine addiction. Am. J. Psychiatry 148: 276.
15. 15. MONTOYA, I.D., F.R. LEVIN, P.J. FUDALA & D.A. GORELICK. 1995. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend. 38: 213-219.
16. B agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 38: 1797-1804.
17. 17. BREBNER, K., R. PHELAN & D.C.S. ROBERTS. 2000. Effect of baclofen on cocaine self-administration reinforced under FR1 and progressive ratio schedules. Psychopharmacology 148: 314-321.
18. 18. BREBNER, K., R. PHELAN & D.C.S. ROBERTS. 2000. Intra-VTA baclofen attenuates cocaine self-administration in rats on a progressive ratio schedule of reinforcement. Pharmacol. Biochem. Behav. In press.
19. 19. DEWEY, S.L., C.S. CHAURASIA, C. CHEN, N.D. VOLKOW, F.S. CLARKSON, S.P. PORTER, R.M. STRAUGHTER-MOORE, D.L. ALEXOFF, D. TEDESCHI, N.B. RUSSO, J.S. FOWLER & J.D. BRODIE. 1997. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25: 393-398.
20. 20. DEWEY, S.L., A. MORGAN, C.R. ASHBY, B. HORAN, S.A. KUSHNER, J. LOGAN, N.D. VOLKOW, J.S. FOWLER, E.L. GARDNER & J.D. BRODIE. 1998. A novel strategy for the treatment of cocaine addiction. Synapse 30: 119-129.
21. 21. GOEDERS, N.E., M.A. MCNULTY, S. MIRKIS & K.H. MCALLISTER. 1989. Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 33: 859-866.
22. 22. GOEDERS, N.E., M.A. MCNULTY & G.F. GUERIN. 1993. Effects of alprazolam on intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 44: 471-474.
23. 23. KUSHNER, S.A., S.L. DEWEY & C. KORNETSKY. 1997. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 133: 383-388.
24. 24. KUSHNER, S.A., S.L. DEWEY & C. KORNETSKY. 1999. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitory γ-vinyl-GABA blocks cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 290: 797-802.
25. B receptor agonists and antagonists. Brain Res. 630: 28-31.
26. 26. SANTIAGO, M., A. MACHADO & J. CANO. 1993. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen. Br. J. Pharmacol. 109: 814-818.
27. B baclofen modifies cocaine self-administration in rats. Behav. Pharmacol. 9: 195-206.
28. 28. CAMPBELL, U.C., S.T. LAC & M.E. CARROLL. 1999. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143: 209-214.
29. 29. ROBERTS, D.C.S., M.M. ANDREWS & G.J. VICKERS. 1996. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15: 417-423.
30. 30. CAINE, S.B. & G.F. KOOB. 1994. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270: 209-218.
31. 31. HUBNER, C.B. & J.E. MORETON. 1991. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105: 151-156.
32. 32. ROBERTS, D.C.S. & K. A. ZITO. 1987. Interpretation of lesion effects on stimulant self-administration. In Methods of Assessing the Reinforcing Properties of Abused Drugs. M.A. Bozarth, Ed. :87-103. Springer-Verlag. New York.
33. 33. DEPOORTERE, R.Y., D.H. LI, J.D. LANE & M.W. EMMETT-OGLESBY. 1993. Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol. Biochem. Behav. 45: 539-548.
34. 34. RICHARDSON, N.R. & D.C.S. ROBERTS. 1996. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66: 1-11.
35. 35. ROBLEDO, P. & G.F. KOOB. 1993. Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav. Brain Res. 30:159-66.
36. 36. KOOB, G.F., F.J. VACCARINO, M. AMALRIC & F.E. BLOOM. 1987. Positive reinforcement properties of drugs: search for neural substrates. In Brain Reward Systems and Abuse. J. Engel & L. Oreland, Eds. :35-50. Raven. New York.
37. 37. MCGREGOR, A., G.B. BAKER & D.C.S. ROBERTS. 1994. Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Brain Res. 646: 273-278.
38. 38. MCGREGOR, A., G.B. BAKER & D.C.S. ROBERTS. 1996. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a preogressive ratio schedule of reinforcement. Pharmacol. Biochem. Behav. 53: 5-9.
39. 39. RICHARDSON, N.R., A.M. SMITH & D.C.S. ROBERTS. 1994. A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug Alcohol Depend. 36: 23-25.
40. 40. ROBERTS, D.C.S, E. LOH & G. VICKERS. 1989. Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97: 535-538
41. 41. MCGREGOR, A. & D.C.S. ROBERTS. 1993. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res. 624: 245-252.
42. 42. MCGREGOR, A. & D.C.S. ROBERTS. 1995. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav. Brain Res. 67: 75-80.
43. 43. BICKEL, W.K., R.J. DE GRANDPRE, S.T. HIGGINS & J.R. HUGHES. 1990. Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose. Life Sci. 47: 1501-1510.
44. 44. CARROLL, M.E., S.T. LAC, M. ASENCIO, J.A. HALIKAS & R. KRAGH. 1990. Effects of carbamazepine on self-administration of intravenously delivered cocaine in rats. Pharmacol. Biochem. Behav. 37: 551-556.
45. 45. CARROLL, M.E., S.T. LAC, M. ASENCIO, J.A. HALIKAS & R. KRAGH. 1990. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35: 237-244.
46. 46. CARROLL, M.E., S.T. LAC, M. ASENCIO, J.A. HALIKAS & R. KRAGH. 1990. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology 100: 293-300.
47. B receptor function. Psychopharmacology 103: 204-208.
48. 48. PAREDES, R. & A. AGMO. 1989. Stereospecific actions of baclofen on sociosexual behavior, locomotor activity and motor execution. Psychopharmacology 97: 358-364.
49. 49. CARROLL, M.E., S.T. LAC & S.L.A. NYGAARD. 1989. A concurrently available non-drug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforcement. Psychopharmacology 97: 23-29.
50. 50. COMER, S.D., S.T. LAC, C.L. WYVELL, L.K. CURTIS, & M.E. CARROLL. 1995. Food deprivation affects extinction and reinstatement of responding in rats. Psychopharmacology 121: 150-157.
51. 51. DE VRY, T., I. DONSELAAR & J.M. VAN REE. 1989. Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J. Pharmacol. Exp. Ther. 251: 735-740.
52. 52. GLICK, S.D., P.A. HINDS & J.N. CARLSON. 1987. Food deprivation and stimulant self-administration in rats: differences between cocaine and d-amphetamine. Psychopharmacology 91: 372-374.
53. 53. ROBERTS, D.C.S. & M. ANDREWS. 1997. Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure. Psychopharmacology 131: 271-277.
54. B agonists and antagonists. Curr. Opin. Ther. Pat. 3: 561-567.
55. B agonists. J. Medicinal Chem. 38: 3297-3312.
56. 56. MORGAN, A.E. & S.L. DEWEY. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28: 60-65.
57. 57. ETTENBERG, A. & T.D. GEIST. 1991. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103: 455-461.
58. 58. MERIRINNE, E., A. KANKAANPÄÄ, P. LILLSUNDE & T. SEPPÄLÄ. 1999. The effects of diazepam and zolpidem on cocaine-and amphetamine-induced place preference. Pharmacol. Biochem. Behav. 62:159-164.
59. 59. ROBERTS, D.C.S & G. VICKERS. 2000. Effect of chlordiazepoxide on cocaine self-administration in rats reinforced on a PR schedule. Submitted.
60. 60. FITCH, T.E. & D.C.S. ROBERTS. 1993. The effects of dose and access restrictions on the periodicity of cocaine self-administration in the rat. Drug Alcohol Depend. 33: 119-128.
61. 61. CHURCHILL, L., R.P. DILTS & P.W. KALIVAS. 1992. Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem. Res. 17: 101-106.
62. 62. KALIVAS, P.W., L. CHURCHILL & M.A. KLITENICK. 1993. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57: 1047-1090.
63. 63. STEFFENSEN, S.C., A.L. SVINGOS, V.M. PICKEL & S.J. HENRIKSEN. 1998. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18: 8003-8015.
64. 64. WHITE, F.J. 1996. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 19: 405-436.
65. 65. VAN BOCKSTAELE, E.J. & V.M. PICKEL. 1995. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 682: 215-221.
66. 66. KITA, H. & S.T. KITAI. 1988. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations. Brain Res. 447: 346-352.
67. 67. WESTERINK, B.H., P. ENRICO, J. FEIMANN & J.B. DE VRIES. 1998. The pharmacology of mesocortical dopamine neurons: a dual probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J. Pharmacol. Exp. Ther. 285: 143-154.
68. 68. WESTERINK, B.H., H.F. KWINT & J.B. DE VRIES. 1996. The pharmacology of mesolimbic dopamine neurons: a dual probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16: 2605-2611.
69. 69. YOSHIDA, M., H. YOKOO, T. TANAKA, H. EMOTO & M. TANAKA. 1994. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636: 111-114.
70. B and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behav. Brain Res. 70: 31-36.
71. B receptors inhibits morphine-induced place preference in rats. Eur. J. Pharmacol. 313: 169-173.
72. 72. XI, Z.X. & E.A. STEIN. 1999. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J. Pharmacol. Exp. Ther. 290: 1369-1374.